CAR T Cell Therapy Market Analysis During 2018–2026 and Growth by Leading Companies: Novartis International, Kite Pharma, Cellectis, Gilead, Celgene, Pfizer
The CAR T therapy uses the patient's own immune system as well as develops it to target the tumor cells and execute them. This therapy is depending on the re-engineering of T-cells to make them recognize cancer cells and target such cells when they generally fail to do so. This therapy has proven very operative in patients with blood cancer who have already gone through alternative therapies such as chemotherapy.
View full press release